- Tous > Medicine Access and Rational Use > Financing
- Tous > Medicine Access and Rational Use > Supply Management
- Mots-clés > cost-saving policies
- Mots-clés > funding medicines
- Mots-clés > hospital pharmacy
- Mots-clés > national medicines list
- Mots-clés > pharmaceutical expenditures - cost analysis
- Mots-clés > pharmaceutical sector - good governance
- Mots-clés > procurement of medicines - public sector
- Mots-clés > public health funds - allocation across medicines
- Mots-clés > public tendering
- Mots-clés > selection of medicines
(2015; 22 pages)
Konduri Niranjan. Lebega Oksana. How Public Funds Were Spent on Procurement of Medicines in Ukraine’s Hospitals? Interim Analysis for the Ministry of Health, Ukraine. Technical Brief # 1. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services Program. Arlington, VA: Management Sciences for Health; June 2015.
Pharmaceuticals may constitute as much as 40% of the health care budget in low and middle-income countries, yet large portions of the population may lack access to even the most essential medicines. The limited public sector funds are frequently spent on ineffective or unnecessary medications. An analysis of past spending patterns on procurement of medicines will help the Ministry of Health policymakers and key government stakeholders in Ukraine for decisions on adopting the national Essential Medicines List (EML) in practice.
The purpose of this technical brief is twofold:
- To demonstrate the need to rationalize limited public funds for maximum health impact.
- To emphasize the need for proper selection of medicines based on WHO recommendations and the rationale for an EML as the sole basis for public sector procurement in Ukraine.
After summarizing high-level data analysis, this technical brief also takes a close look at insulins and analogues that account for the most expenditure.